- Percutaneous transluminal coronary angioplasty for ostial stenosis of the left coronary artery
-
Lee HY
- KMID: 1093810
- Yonsei Med J.
- 1995 Oct;36(5):462-465.
- doi: 10.3349/ymj.1995.36.5.462
A 11-year-old girl developed left main coronary artery osteal stenosis after Takayasu's arteritis for which she underwent Percutaneous Transluminal Coronary Angioplasty (PTCA). The narrowing of the left coronary artery was... -
- CITED
-
- Close
- SHARE
-
- Close
- Percutaneous Transluminal Coronary Angioplasty for Coronary Artery Stenosis in a Young Patient with Long Term Kawasaki Disease
-
Hong SI, Kim PJ, Seung KB, Kwon JH, Beak JY, Yeo CD, Choi KB
- KMID: 1718046
- Korean J Intern Med.
- 2005 Jun;20(2):187-190.
- doi: 10.3904/kjim.2005.20.2.187
Kawasaki Disease (KD) is an acute, febrile, multisystem disease of children. More severe complications in 15~25% of cases include, the development of coronary aneurysms, ischemic heart disease, and sudden cardiac... -
- CITED
-
- Close
- SHARE
-
- Close
- Changes in N-terminal Pro B-type Natriuretic Peptide Concentration: Comparative Study of Percutaneous Transluminal Coronary Angioplasty and Off-Pump Coronary Artery Bypass Graft
-
Kim HK, Kim HJ, Kim JW, Sohn YS, Choi YH
- KMID: 1713223
- J Korean Med Sci.
- 2007 Feb;22(1):16-19.
- doi: 10.3346/jkms.2007.22.1.16
The goal of this study was to compare the effects of different reperfusion methods on N-terminal B-type natriuretic peptide (NT-proBNP) in percutaneous transluminal coronary angioplasty (PTCA) or off-pump coronary artery... -
- CITED
-
- Close
- SHARE
-
- Close
- Percutaneous Coronary Intervention versus Coronary Artery Bypass Grafting for Diabetics with Multivessel Coronary Artery Disease: The Korean Multicenter Revascularization Registry (KORR)
-
Gwon HC, Choi SH, Choi BI, Cho SY, Ro YM, Lee WR, KORR Investigators
- KMID: 1095189
- J Korean Med Sci.
- 2005 Apr;20(2):196-203.
- doi: 10.3346/jkms.2005.20.2.196
This study was designed to assess the relative merits of percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) in multivessel coronary artery disease (MVCAD), particularly for Korean diabetics.... -
- CITED
-
- Close
- SHARE
-
- Close
- Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction with Idiopathic Thrombocytopenic Purpura: A Case Report
-
Kim JH, Park KU, Chun WJ, Kim SH, Nah DY
- KMID: 1781850
- J Korean Med Sci.
- 2006 Apr;21(2):355-357.
- doi: 10.3346/jkms.2006.21.2.355
Acute myocardial infarction (AMI) is rare in patients with idiopathic thrombocytopenic purpura (ITP). We describe a case of an AMI during thrombocytopenia in a patient with chronic ITP. A 47-yr-old... -
- CITED
-
- Close
- SHARE
-
- Close
- Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients with Coronary Artery Disease and Diabetic Nephropathy: A Single Center Experience
-
Bae KS, Park HC, Kang BS, Park JW, Chon NR, Oh KJ, Yoon YW, Hong YS, Ha SK
- KMID: 1785618
- Korean J Intern Med.
- 2007 Sep;22(3):139-146.
- doi: 10.3904/kjim.2007.22.3.139
BACKGROUND: Patients with diabetic nephropathy (DN) and coronary artery disease (CAD) represent a subset of patients with high cardiovascular morbidity and mortality. The optimal revascularization strategy using either percutaneous... -
- CITED
-
- Close
- SHARE
-
- Close
- Coronary Artery Intervention after Cytostatics Treatment in Unstable Angina Patient with Essential Thrombocythemia: A Case Report and Literature Review
-
Chang H, Shim CY, Cheong JW, Pyo JY, Ko YG, Choi D, Jang Y
- KMID: 1785615
- Korean J Intern Med.
- 2006 Jun;21(2):146-149.
- doi: 10.3904/kjim.2006.21.2.146
Essential thrombocythemia (ET) is a clonal disorder of myeloid stem cells that causes thrombocytosis. As a result, ET can lead to vascular thrombosis and tissue ischemia; the association of coronary... -
- CITED
-
- Close
- SHARE
-
- Close
- A Comparative Study on Comorbidity Measurements with Lookback Period using Health Insurance Database: Focused on Patients Who Underwent Percutaneous Coronary Intervention
-
Kim KH, Ahn LS
- KMID: 1008663
- J Prev Med Public Health.
- 2009 Jul;42(4):267-273.
- doi: 10.3961/jpmph.2009.42.4.267
OBJECTIVES: To compare the performance of three comorbidity measurements (Charlson comorbidity index, Elixhauser's comorbidity and comorbidity selection) with the effect of different comorbidity lookback periods when predicting in-hospital mortality for... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Insulin Resistance on Prognosis of Non-Diabetic Patients Who Underwent Percutaneous Coronary Intervention
-
Yun KH, Jeong MH, Kim KH, Hong YJ, Park HW, Kim JH, Ahn YK, Cho JG, Park JC, Kim NH, Oh SK, Jeong JW, Kang JC
- KMID: 1781824
- J Korean Med Sci.
- 2006 Apr;21(2):212-216.
- doi: 10.3346/jkms.2006.21.2.212
Insulin resistance is an important risk factor for coronary artery disease. However, there has been no data regarding its clinical effect on the outcomes of percutaneous coronary intervention (PCI) in... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Significance of On-Treatment Triglyceride Level in Patients Treated by Percutaneous Coronary Intervention for Non-ST-Segment Elevation Acute Coronary Syndrome
-
Yun KH, Shin IS, Rhee SJ, Lee EM, Yoo NJ, Kim NH, Oh SK, Jeong JW
- KMID: 1776661
- Korean J Intern Med.
- 2009 Dec;24(4):330-336.
- doi: 10.3904/kjim.2009.24.4.330
BACKGROUND/AIMS: The use of statins in patients with acute coronary syndrome (ACS) has increased, and reduced levels of low-density lipoprotein cholesterol (LDL-C) lead to lower coronary event rates. We studied... -
- CITED
-
- Close
- SHARE
-
- Close
- A Multicenter, Randomized, Open-Label, Therapeutic, and Exploratory Trial to Evaluate the Tolerability and Efficacy of Platelet Glycoprotein IIb/IIIa Receptor Blocker (Clotinab(TM)) in High-Risk Patients with Percutaneous Coronary Intervention
-
Moon JY, Kim W, Kim JH, Ahn Y, Jeong MH, Kim YH, Hong MK, Park SW, Park SJ, Park S, Ko YG, Choi D, Jang Y
- KMID: 724253
- Yonsei Med J.
- 2008 Jun;49(3):389-399.
- doi: 10.3349/ymj.2008.49.3.389
PURPOSE: This study was designed as a multicenter, randomized, open-label study to evaluate the efficacy and tolerability of Clotinab(TM). We expected to obtain same results as with ReoPro(R) in improving... -
- CITED
-
- Close
- SHARE
-
- Close
- An Elevated Value of C-Reactive Protein is the Only Predictive Factor of Restenosis after Percutaneous Coronary Intervention
-
Jeong WK, Jeong MH, Kim KH, Lee SR, Park OY, Yum JH, Kim JH, Kim W, Rhew JY, Ahn YK, Cho JG, Ahn BH, Suh SP, Park JC, Kim SH, Kang JC
- KMID: 759654
- Korean J Intern Med.
- 2003 Sep;18(3):154-160.
BACKGROUND: The current techniques for percutaneous coronary interventions (PCI) remain limited by restenosis. Recent studies have provided evidence of inflammation playing a role in the pathogenesis of cardiovascular disease. METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
- The use of Low Molecular Weight Heparin to Predict Clinical Outcome in Patients with Unstable Angina That Had Undergone Percutaneous Coronary Intervention
-
Hong YJ, Jeong MH, Lee SH, Park OY, Kim JH, Kim W, Rhew JY, Ahn YK, Cho JG, Park JC, Suh SP, Ahn BH, Kim SH, Kang JC
- KMID: 759656
- Korean J Intern Med.
- 2003 Sep;18(3):167-173.
BACKGROUND: Antithrombotic therapy with heparin reduces the rate of ischemic events in patients with acute coronary syndrome. Low-molecular-weight heparin, given subcutaneously twice daily, has a more predictable anticoagulant effect than... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Direct Communication between Emergency Physicians and Interventional Cardiologists on Door to Balloon Times in STEMI
-
Kwak MJ, Kim K, Rhee JE, Shin JH, Suh GJ, Jo YS, Youn TJ, Chung WY, Chae IH, Choi DJ, Lee CC, Singer AJ
- KMID: 1785833
- J Korean Med Sci.
- 2008 Aug;23(4):706-710.
- doi: 10.3346/jkms.2008.23.4.706
We developed an institutional protocol mandating emergency physicians to contact the interventional cardiologist directly in all cases of ST-segment elevation myocardial infarction (STEMI) and hypothesized that this would reduce door-to-balloontimes... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-Term Clinical Benefits of a Platelet Glycoprotein IIb/IIIa Receptor Blocker, Abciximab (ReoPro (R) ), in High-Risk Diabetic Patients undergoing Percutaneous Coronary Intervention
-
Sim DS, Jeong MH, Kim W, Rhew JY, Yum JH, Kim JH, Cho JG, Ahn YK, Park JC, Ahn BH, Kim SH, Kang JC
- KMID: 759651
- Korean J Intern Med.
- 2003 Sep;18(3):129-137.
BACKGROUND: High-risk percutaneous coronary interventions (PCIs) are associated with a high complication rate, a low procedural success rate and a high restenosis rate, especially in diabetics. We sought to determine... -
- CITED
-
- Close
- SHARE
-
- Close
